Recent Treatment Patterns of Oropharyngeal Cancer in Korea Based on the Expert Questionnaire Survey of the Korean Society for Head and Neck Oncology (KSHNO)

Purpose The incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are challenging. A questionnaire survey was conducted to investigate the controversial treatment policy of stage T2 OPC according to the N category and...

Full description

Saved in:
Bibliographic Details
Published inCancer Research and Treatment Vol. 53; no. 4; pp. 1004 - 1014
Main Authors Choi, Kyu Hye, Song, Jin Ho, Kim, Yeon-Sil, Kim, Ji-hoon, Jeong, Woo-Jin, Nam, Inn-Chul, Kim, Jin Ho, Ahn, Hee Kyung, Chun, Sang Hoon, Hong, Hyun Jun, Joo, Young-Hoon, Eun, Young-Gyu, Moon, Sung Ho, Lee, Jeongshim
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Cancer Association 01.10.2021
대한암학회
Subjects
Online AccessGet full text
ISSN1598-2998
2005-9256
2005-9256
DOI10.4143/crt.2020.973

Cover

Abstract Purpose The incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are challenging. A questionnaire survey was conducted to investigate the controversial treatment policy of stage T2 OPC according to the N category and determine the opinions of multidisciplinary experts in Korea.Materials and Methods Five OPC scenarios were developed by the Subcommittee on Oropharyngeal Treatment Guidelines of the Korean Society for Head and Neck Oncology and distributed to experts of multidisciplinary treatment hospitals.Results Sixty-five experts from 45 institutions responded. For the HPV-positive T2N0M0 scenario, 67.7% of respondents selected surgery followed by definitive concurrent chemoradiotherapy (CCRT) or radiotherapy alone. For the T2N1M0 HPV-positive scenario, there was a notable difference in the selection of primary treatment by expert specialty; 53.9% of respondents selected surgery and 39.8% selected definitive CCRT as the primary treatment. For the T2N3M0 advanced HPV-positive scenario, 50.0% of respondents selected CCRT and 33.3% considered induction chemotherapy (IC) as the primary treatment. CCRT and IC were significantly more frequently selected for the HPV-related OPC cases (p=0.010). The interdepartmental variability showed that the head and neck surgeons and medical oncologists favored surgery, whereas the radiation oncologists preferably selected definitive CCRT (p < 0.001).Conclusion In this study, surgery was preferred for lymph node-negative OPC, and as lymph node metastasis progressed, CCRT tended to be preferred, and IC was administered. Clinical practice patterns by stage and HPV status showed differences according to expert specialty. Multidisciplinary consensus guidelines will be essential in the future.
AbstractList The incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are challenging. A questionnaire survey was conducted to investigate the controversial treatment policy of stage T2 OPC according to the N category and determine the opinions of multidisciplinary experts in Korea. Five OPC scenarios were developed by the Subcommittee on Oropharyngeal Treatment Guidelines of the Korean Society for Head and Neck Oncology and distributed to experts of multidisciplinary treatment hospitals. Sixty-five experts from 45 institutions responded. For the HPV-positive T2N0M0 scenario, 67.7% of respondents selected surgery followed by definitive concurrent chemoradiotherapy (CCRT) or radiotherapy alone. For the T2N1M0 HPV-positive scenario, there was a notable difference in the selection of primary treatment by expert specialty; 53.9% of respondents selected surgery and 39.8% selected definitive CCRT as the primary treatment. For the T2N3M0 advanced HPV-positive scenario, 50.0% of respondents selected CCRT and 33.3% considered induction chemotherapy (IC) as the primary treatment. CCRT and IC were significantly more frequently selected for the HPV-related OPC cases (p=0.010). The interdepartmental variability showed that the head and neck surgeons and medical oncologists favored surgery, whereas the radiation oncologists preferably selected definitive CCRT (p < 0.001). In this study, surgery was preferred for lymph node-negative OPC, and as lymph node metastasis progressed, CCRT tended to be preferred, and IC was administered. Clinical practice patterns by stage and HPV status showed differences according to expert specialty. Multidisciplinary consensus guidelines will be essential in the future.
Purpose The incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are challenging. A questionnaire survey was conducted to investigate the controversial treatment policy of stage T2 OPC according to the N category and determine the opinions of multidisciplinary experts in Korea. Materials and Methods Five OPC scenarios were developed by the Subcommittee on Oropharyngeal Treatment Guidelines of the Korean Society for Head and Neck Oncology and distributed to experts of multidisciplinary treatment hospitals. Results Sixty-five experts from 45 institutions responded. For the HPV-positive T2N0M0 scenario, 67.7% of respondents selected surgery followed by definitive concurrent chemoradiotherapy (CCRT) or radiotherapy alone. For the T2N1M0 HPV-positive scenario, there was a notable difference in the selection of primary treatment by expert specialty; 53.9% of respondents selected surgery and 39.8% selected definitive CCRT as the primary treatment. For the T2N3M0 advanced HPV-positive scenario, 50.0% of respondents selected CCRT and 33.3% considered induction chemotherapy (IC) as the primary treatment. CCRT and IC were significantly more frequently selected for the HPV-related OPC cases (p=0.010). The interdepartmental variability showed that the head and neck surgeons and medical oncologists favored surgery, whereas the radiation oncologists preferably selected definitive CCRT (p < 0.001). Conclusion In this study, surgery was preferred for lymph node-negative OPC, and as lymph node metastasis progressed, CCRT tended to be preferred, and IC was administered. Clinical practice patterns by stage and HPV status showed differences according to expert specialty. Multidisciplinary consensus guidelines will be essential in the future. KCI Citation Count: 0
Purpose The incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are challenging. A questionnaire survey was conducted to investigate the controversial treatment policy of stage T2 OPC according to the N category and determine the opinions of multidisciplinary experts in Korea.Materials and Methods Five OPC scenarios were developed by the Subcommittee on Oropharyngeal Treatment Guidelines of the Korean Society for Head and Neck Oncology and distributed to experts of multidisciplinary treatment hospitals.Results Sixty-five experts from 45 institutions responded. For the HPV-positive T2N0M0 scenario, 67.7% of respondents selected surgery followed by definitive concurrent chemoradiotherapy (CCRT) or radiotherapy alone. For the T2N1M0 HPV-positive scenario, there was a notable difference in the selection of primary treatment by expert specialty; 53.9% of respondents selected surgery and 39.8% selected definitive CCRT as the primary treatment. For the T2N3M0 advanced HPV-positive scenario, 50.0% of respondents selected CCRT and 33.3% considered induction chemotherapy (IC) as the primary treatment. CCRT and IC were significantly more frequently selected for the HPV-related OPC cases (p=0.010). The interdepartmental variability showed that the head and neck surgeons and medical oncologists favored surgery, whereas the radiation oncologists preferably selected definitive CCRT (p < 0.001).Conclusion In this study, surgery was preferred for lymph node-negative OPC, and as lymph node metastasis progressed, CCRT tended to be preferred, and IC was administered. Clinical practice patterns by stage and HPV status showed differences according to expert specialty. Multidisciplinary consensus guidelines will be essential in the future.
The incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are challenging. A questionnaire survey was conducted to investigate the controversial treatment policy of stage T2 OPC according to the N category and determine the opinions of multidisciplinary experts in Korea.PURPOSEThe incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are challenging. A questionnaire survey was conducted to investigate the controversial treatment policy of stage T2 OPC according to the N category and determine the opinions of multidisciplinary experts in Korea.Five OPC scenarios were developed by the Subcommittee on Oropharyngeal Treatment Guidelines of the Korean Society for Head and Neck Oncology and distributed to experts of multidisciplinary treatment hospitals.MATERIALS AND METHODSFive OPC scenarios were developed by the Subcommittee on Oropharyngeal Treatment Guidelines of the Korean Society for Head and Neck Oncology and distributed to experts of multidisciplinary treatment hospitals.Sixty-five experts from 45 institutions responded. For the HPV-positive T2N0M0 scenario, 67.7% of respondents selected surgery followed by definitive concurrent chemoradiotherapy (CCRT) or radiotherapy alone. For the T2N1M0 HPV-positive scenario, there was a notable difference in the selection of primary treatment by expert specialty; 53.9% of respondents selected surgery and 39.8% selected definitive CCRT as the primary treatment. For the T2N3M0 advanced HPV-positive scenario, 50.0% of respondents selected CCRT and 33.3% considered induction chemotherapy (IC) as the primary treatment. CCRT and IC were significantly more frequently selected for the HPV-related OPC cases (p=0.010). The interdepartmental variability showed that the head and neck surgeons and medical oncologists favored surgery, whereas the radiation oncologists preferably selected definitive CCRT (p < 0.001).RESULTSSixty-five experts from 45 institutions responded. For the HPV-positive T2N0M0 scenario, 67.7% of respondents selected surgery followed by definitive concurrent chemoradiotherapy (CCRT) or radiotherapy alone. For the T2N1M0 HPV-positive scenario, there was a notable difference in the selection of primary treatment by expert specialty; 53.9% of respondents selected surgery and 39.8% selected definitive CCRT as the primary treatment. For the T2N3M0 advanced HPV-positive scenario, 50.0% of respondents selected CCRT and 33.3% considered induction chemotherapy (IC) as the primary treatment. CCRT and IC were significantly more frequently selected for the HPV-related OPC cases (p=0.010). The interdepartmental variability showed that the head and neck surgeons and medical oncologists favored surgery, whereas the radiation oncologists preferably selected definitive CCRT (p < 0.001).In this study, surgery was preferred for lymph node-negative OPC, and as lymph node metastasis progressed, CCRT tended to be preferred, and IC was administered. Clinical practice patterns by stage and HPV status showed differences according to expert specialty. Multidisciplinary consensus guidelines will be essential in the future.CONCLUSIONIn this study, surgery was preferred for lymph node-negative OPC, and as lymph node metastasis progressed, CCRT tended to be preferred, and IC was administered. Clinical practice patterns by stage and HPV status showed differences according to expert specialty. Multidisciplinary consensus guidelines will be essential in the future.
Author Woo Jin Jeong
Jin Ho Song
Yeon-Sil Kim
Hyun Jun Hong
Ji Hoon Kim
Jeongshim Lee
Young Hoon Joo
Young Gyu Eun
Hee Kyung Ahn
Inn-Chul Nam
Sung Ho Moon
Kye Hye Choi
Jin Ho Kim
Sang Hoon Chun
AuthorAffiliation 2 Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
3 Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
11 Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Korea
10 Department of Otolaryngology-Head and Neck Surgery, Kyung Hee University School of Medicine, Seoul, Korea
6 Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea
8 Department of Otorhinolaryngology-Head and Neck Surgery, International St. Mary’s Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea
7 Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
9 Department of Otolaryngology-Head and Neck Surgery, Bucheon St. Mary’s Hospital, College of Medicine, The Ca
AuthorAffiliation_xml – name: 2 Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
– name: 9 Department of Otolaryngology-Head and Neck Surgery, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
– name: 7 Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
– name: 6 Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea
– name: 1 Department of Radiation Oncology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
– name: 4 Department of Otolaryngology-Head and Neck Surgery, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
– name: 3 Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
– name: 12 Department of Radiation Oncology, Inha University Hospital, Inha University School of Medicine, Incheon, Korea
– name: 10 Department of Otolaryngology-Head and Neck Surgery, Kyung Hee University School of Medicine, Seoul, Korea
– name: 5 Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
– name: 8 Department of Otorhinolaryngology-Head and Neck Surgery, International St. Mary’s Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea
– name: 11 Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Korea
Author_xml – sequence: 1
  givenname: Kyu Hye
  surname: Choi
  fullname: Choi, Kyu Hye
– sequence: 2
  givenname: Jin Ho
  surname: Song
  fullname: Song, Jin Ho
– sequence: 3
  givenname: Yeon-Sil
  surname: Kim
  fullname: Kim, Yeon-Sil
– sequence: 4
  givenname: Ji-hoon
  surname: Kim
  fullname: Kim, Ji-hoon
– sequence: 5
  givenname: Woo-Jin
  surname: Jeong
  fullname: Jeong, Woo-Jin
– sequence: 6
  givenname: Inn-Chul
  surname: Nam
  fullname: Nam, Inn-Chul
– sequence: 7
  givenname: Jin Ho
  surname: Kim
  fullname: Kim, Jin Ho
– sequence: 8
  givenname: Hee Kyung
  surname: Ahn
  fullname: Ahn, Hee Kyung
– sequence: 9
  givenname: Sang Hoon
  surname: Chun
  fullname: Chun, Sang Hoon
– sequence: 10
  givenname: Hyun Jun
  surname: Hong
  fullname: Hong, Hyun Jun
– sequence: 11
  givenname: Young-Hoon
  surname: Joo
  fullname: Joo, Young-Hoon
– sequence: 12
  givenname: Young-Gyu
  surname: Eun
  fullname: Eun, Young-Gyu
– sequence: 13
  givenname: Sung Ho
  surname: Moon
  fullname: Moon, Sung Ho
– sequence: 14
  givenname: Jeongshim
  surname: Lee
  fullname: Lee, Jeongshim
BackLink https://cir.nii.ac.jp/crid/1872553967779608448$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/33540495$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002764927$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1Uk1v0zAYttAQ6wo3zsgHDptEipPYcXyZNKpBp00rrOVsOc6b1jS1i-NO9L_wY3HaDgESF7-W_Hy8evycoRPrLCD0OiUjmtL8vfZhlJGMjATPn6FBRghLRMaKEzRImSiTTIjyFJ113TdCCprz9AU6zXNGCRVsgH4-gAYb8NyDCuv-9lmFAN522DV46t1mqfzOLkC1eKysBo-NxbcuwvEH1UGNncVhCfj6xwZ8wF-20AXjrFXGA55t_SPseqUesmdZPHPaQNjhxnk8AVVjZWt8D3qFp1a71i12-Px2NrmfXrxEzxvVdvDqOIfo68fr-XiS3E0_3Yyv7hLN0jwkBdVFrSrORKZpzYWASqUUspJlVU5VURLBK8oZ4YKIuiCcFKypmqYRtKwqDfkQXRx0rW_kShvplNnPhZMrL68e5jdSlJyIaDdElwfsZlutoe7D86qVG2_WMag98-8Xa5ZR51HGbShJyyhwfhTw7nufllybTkPbKgtu28mMljxllNHe682fXr9Nnr4vArIDQHvXdR4aqU1Qff7R2rQyJbLviIwdkX1HZOxIJL37h_Sk-x_422M4xkT5_kxLnjGWi4JzLgpSUlrmvwD93sjs
CitedBy_id crossref_primary_10_1016_j_cllc_2022_02_001
crossref_primary_10_3857_roj_2021_00556
Cites_doi 10.3857/roj.2017.00465
10.1016/s1470-2045(13)70011-1
10.1016/0167-8140(90)90162-p
10.1016/s1470-2045(10)70279-5
10.1002/14651858.cd010271.pub2
10.5037/jomr.2010.1301
10.3201/eid1611.100452
10.1200/jco.2011.36.4596
10.1093/annonc/mdt461
10.1016/j.prro.2017.02.002
10.1158/0008-5472.can-16-0633
10.1200/jco.2007.14.8841
10.1200/jco.2013.54.6309
10.1002/cncr.28595
10.1016/j.pvr.2018.12.002
10.1016/s1470-2045(15)00560-4
10.1056/nejmoa070956
10.1200/jco.2012.43.6097
10.1016/j.ijrobp.2019.08.038
10.1002/cncr.30508
10.1200/jco.2004.08.021
10.1093/annonc/mdu265
10.1016/j.ijrobp.2015.08.033
10.1200/jco.18.01921
10.1200/jco.2012.44.0164
ContentType Journal Article
Copyright Copyright © 2021 by the Korean Cancer Association 2021
Copyright_xml – notice: Copyright © 2021 by the Korean Cancer Association 2021
DBID RYH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ACYCR
DOI 10.4143/crt.2020.973
DatabaseName CiNii Complete
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2005-9256
EndPage 1014
ExternalDocumentID oai_kci_go_kr_ARTI_9870951
PMC8524018
33540495
10_4143_crt_2020_973
Genre Journal Article
Case Reports
GeographicLocations Republic of Korea
GeographicLocations_xml – name: Republic of Korea
GrantInformation_xml – fundername: Korean Society for Head and Neck Oncology
GroupedDBID ---
29B
5-W
53G
8JR
9ZL
ABDBF
ACUHS
ACYCR
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
DIK
E3Z
EBD
EF.
F5P
HYE
OK1
RPM
RYH
TR2
AAYXX
CITATION
C1A
CGR
CUY
CVF
ECM
EIF
M~E
NPM
7X8
5PM
ID FETCH-LOGICAL-c513t-64c6dab7592c4d799eba14e2852b34a68097b47507909d607065fbfff948bbce3
ISSN 1598-2998
2005-9256
IngestDate Sun Mar 09 07:51:09 EDT 2025
Thu Aug 21 14:08:45 EDT 2025
Fri Jul 11 09:24:35 EDT 2025
Thu Jan 02 22:54:58 EST 2025
Thu Apr 24 23:07:30 EDT 2025
Tue Jul 01 03:18:50 EDT 2025
Thu Jun 26 21:58:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Questionnaire study
Human papillomavirus
Oropharyngeal neoploasms
Treatment patterns
Language English
License This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c513t-64c6dab7592c4d799eba14e2852b34a68097b47507909d607065fbfff948bbce3
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ORCID 0000-0002-4662-1916
0000-0002-5847-7317
0000-0002-7808-7877
0000-0002-7918-1072
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC8524018
PMID 33540495
PQID 2487154541
PQPubID 23479
PageCount 11
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_9870951
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8524018
proquest_miscellaneous_2487154541
pubmed_primary_33540495
crossref_citationtrail_10_4143_crt_2020_973
crossref_primary_10_4143_crt_2020_973
nii_cinii_1872553967779608448
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-10-01
PublicationDateYYYYMMDD 2021-10-01
PublicationDate_xml – month: 10
  year: 2021
  text: 2021-10-01
  day: 01
PublicationDecade 2020
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Cancer Research and Treatment
PublicationTitleAlternate Cancer Res Treat
PublicationYear 2021
Publisher Korean Cancer Association
대한암학회
Publisher_xml – name: Korean Cancer Association
– name: 대한암학회
References ref13
ref12
ref15
ref14
ref30
ref11
ref10
ref2
ref1
(ref25) 2020
ref16
ref19
Mehanna (ref18) 2019
Golusinski (ref21) 2019
ref24
ref23
ref26
ref20
ref22
Elrefaey (ref5) 2014
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
Gillison (ref17) 2019
References_xml – ident: ref7
  doi: 10.3857/roj.2017.00465
– start-page: 51
  volume-title: Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
  year: 2019
  ident: ref18
– start-page: 388
  volume-title: Current role of surgery in the management of oropharyngeal cancer
  year: 2019
  ident: ref21
– ident: ref27
  doi: 10.1016/s1470-2045(13)70011-1
– ident: ref22
  doi: 10.1016/0167-8140(90)90162-p
– ident: ref30
  doi: 10.1016/s1470-2045(10)70279-5
– ident: ref13
  doi: 10.1002/14651858.cd010271.pub2
– ident: ref24
  doi: 10.5037/jomr.2010.1301
– ident: ref2
  doi: 10.3201/eid1611.100452
– ident: ref3
  doi: 10.1200/jco.2011.36.4596
– ident: ref28
  doi: 10.1093/annonc/mdt461
– ident: ref9
  doi: 10.1016/j.prro.2017.02.002
– ident: ref4
  doi: 10.1158/0008-5472.can-16-0633
– ident: ref23
  doi: 10.1200/jco.2007.14.8841
– year: 2020
  ident: ref25
– ident: ref26
  doi: 10.1200/jco.2013.54.6309
– ident: ref6
  doi: 10.1002/cncr.28595
– ident: ref8
  doi: 10.1016/j.pvr.2018.12.002
– ident: ref1
  doi: 10.1016/s1470-2045(15)00560-4
– ident: ref29
  doi: 10.1056/nejmoa070956
– start-page: 40
  volume-title: Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
  year: 2019
  ident: ref17
– start-page: 299
  volume-title: HPV in oropharyngeal cancer: the basics to know in clinical practice
  year: 2014
  ident: ref5
– ident: ref16
  doi: 10.1200/jco.2012.43.6097
– ident: ref20
  doi: 10.1016/j.ijrobp.2019.08.038
– ident: ref15
  doi: 10.1002/cncr.30508
– ident: ref14
  doi: 10.1200/jco.2004.08.021
– ident: ref11
  doi: 10.1093/annonc/mdu265
– ident: ref19
  doi: 10.1016/j.ijrobp.2015.08.033
– ident: ref10
  doi: 10.1200/jco.18.01921
– ident: ref12
  doi: 10.1200/jco.2012.44.0164
SSID ssj0064371
Score 2.2444506
SecondaryResourceType review_article
Snippet Purpose The incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are...
The incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are challenging. A...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
nii
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1004
SubjectTerms Aged
Carcinoma, Squamous Cell
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - therapy
Carcinoma, Squamous Cell - virology
Chemoradiotherapy
Chemoradiotherapy - methods
Combined Modality Therapy
Female
Follow-Up Studies
Humans
Male
Middle Aged
Original
Oropharyngeal Neoplasms
Oropharyngeal Neoplasms - pathology
Oropharyngeal Neoplasms - therapy
Oropharyngeal Neoplasms - virology
Papillomaviridae
Papillomaviridae - isolation & purification
Papillomavirus Infections
Papillomavirus Infections - complications
Papillomavirus Infections - virology
Practice Patterns, Physicians
Practice Patterns, Physicians' - statistics & numerical data
Prognosis
Republic of Korea
Robotic Surgical Procedures
Robotic Surgical Procedures - methods
Surveys and Questionnaires
의학일반
Title Recent Treatment Patterns of Oropharyngeal Cancer in Korea Based on the Expert Questionnaire Survey of the Korean Society for Head and Neck Oncology (KSHNO)
URI https://cir.nii.ac.jp/crid/1872553967779608448
https://www.ncbi.nlm.nih.gov/pubmed/33540495
https://www.proquest.com/docview/2487154541
https://pubmed.ncbi.nlm.nih.gov/PMC8524018
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002764927
Volume 53
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Cancer Research and Treatment, 2021, 53(4), , pp.1004-1014
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwGLV2kaa9IO4UGDIIJFCVLXGcix_XwVQ2sSFtk8ZTFDvOVg2cKbRI5bfwxh_l--wkbadOAl7cKnGcKOfE_mwfHxPyminuy1RLL0qT0uNBzjypAu6VChpDqZnyc6u2OIqHZ_zgPDpfWfk9p1qajOW2-rl0Xcn_oArHAFdcJfsPyHaFwgH4D_hCCghD-lcYQ8yHU_mnnVj8s3XLdMq247q6vszrqblA7-A9RBel5_3DCrL3B9B6Fc1MgfM7Hvft4Cc8rMmhHoQqpf6hp62GwF5lFkSeQ6CHnXs40uqqf2yUs3OCkPXwZHh03I4xzGwQ8AEacyG3nq5Tuc9EBpVTF0wn_eG049xJqxtGY65qJhuwXP6iK-OdzJQizeGDkTesGs41oxos6PRx0CjZ2s9apArmXMfbqtr5CjeU5HP1LvreLWsQOISDgKKqUTbL_G3h9k2Z48b1N0uOEMe_uNvv84YBd3tqlayzBAK0NbK-O3g_2G8bfJz6DNyaCrzdzvzNNslGe_lC4LNqRiNM63JZz-amQHcu4jm9S-40XRW663h3j6xoc59sfGrEGA_IL0c_2tGPtvSjVUkX6Ecd-nRkqCUStfSjlaHALeroRxfoRx39sCTM4uhHG_pRoB9F-lFgEUX60ZZ-9K0l37uH5Gz_w-ne0Gs2-_BUFIRjL-YqLnKZRAKqjyIRQss84JqlEZMhz-PUF4nkEN8mwhdF7OP0fCnLshQ8lVLp8BFZM5XRTwiNUqaLkoVaFYprWaRJoQAiFqpQqYiJHum3SGSqccLHDVm-ZtAjRggzgDBDCDOAsEfedLmvnQPMLfm2AFQoENMgTaCvHoo4SRIR-ynnaY-8ArizKzXK0NIdfy-q7KrOoOP6MRPQbkJnp0detmzIoJ7Hybvc6GryPWM8TbC7wyHPY8eO7nFaivVIssCbLgPecPGMGV1aL3l4vdwP0qe3lvmMbM6-z-dkbVxP9BbE4WP5ovkO_gDmFt4n
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recent+Treatment+Patterns+of+Oropharyngeal+Cancer+in+Korea+Based+on+the+Expert+Questionnaire+Survey+of+the+Korean+Society+for+Head+and+Neck+Oncology+%28KSHNO%29&rft.jtitle=Cancer+research+and+treatment&rft.au=Choi%2C+Kyu+Hye&rft.au=Song%2C+Jin+Ho&rft.au=Kim%2C+Yeon-Sil&rft.au=Kim%2C+Ji-Hoon&rft.date=2021-10-01&rft.eissn=2005-9256&rft.volume=53&rft.issue=4&rft.spage=1004&rft_id=info:doi/10.4143%2Fcrt.2020.973&rft_id=info%3Apmid%2F33540495&rft.externalDocID=33540495
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1598-2998&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1598-2998&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1598-2998&client=summon